πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

18 results for β€œtranexamic” Clear

  1. FIBRINOGEN, HUMAN, RIVAROXABAN , APIXABAN , ETAMSYLATE , TRANEXAMIC ACID , -, PROTAMINE , -, ERYTHROCYTES , AMINOMETHYLBENZOIC ACID , -, AMINOCAPROIC ACID , Ondexxya 200 mg powder for solution for infusion, EDOXABAN , -

    AstraZeneca AB

    Reversal of anticoagulation effect in patients on a FXa inhibitor (apixaban, rivaroxaban, or edoxaban) who require urgent surgery or procedure, and who have a major risk of bleeding.

    phase 3 small molecule active

    1 trial

  2. NaCl 0.9%, TRANEXAMIC ACID, TERLIPRESSIN

    Pari Pharma GmbH

    Hemoptysis, whatever the cause, with the exception of cystic fibrosis

    phase 3 small molecule active

    1 trial

  3. Tranexamic Acid

    United Therapeutics Europe Ltd

    Spinal Injuries

    phase 3 small molecule active

    1 trial

  4. Tranexamic Acid

    Arrowhead Pharmaceuticals Ireland Limited

    Hemorrhagic Shock

    phase 3 small molecule completed

    1 trial

  5. Tranexamic acid

    The First People's Hospital of Lianyungang

    Hemorrhage, Postpartum

    phase 3 small molecule completed

    1 trial

  6. pad-gauze with tranexamic acid (Hemostopanβ„’)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  7. Tranexamic Acid

    United Therapeutics Europe Ltd

    Hemorrhage

    phase 2 small molecule completed

    1 trial

  8. Tranexamic Acid

    Neuroscience Trials Australia

    Intracerebral Haemorrhage

    phase 2 small molecule completed

    1 trial

  9. Tranexamic Acid

    United Therapeutics Europe Ltd

    Anterior Cruciate Ligament Reconstruction

    phase 2 small molecule active

    1 trial

  10. Tranexamic AcidοΌ›

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Iatrogenic Endobronchial Bleeding

    phase 1 small molecule active

    1 trial

  11. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-CalvΓ©-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial

  12. TRANEXAMIC ACID

    The George Institute

    Hip fracture

    approved small molecule active

    1 trial

  13. Tranexamic Acid

    The First People's Hospital of Lianyungang

    Postpartum Hemorrhage， Cesarean Section

    approved small molecule active

    1 trial

  14. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial

  15. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  16. Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

    Hospital Authority, Hong Kong

    Rotator Cuff Tears

    small molecule completed

    1 trial

  17. Tranexamic acid (TXA)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Blood Loss

    small molecule active

    1 trial

  18. tranexamic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Transplantation

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources